Percutaneous absorption of [7.10-14C]benzo[a]pyrene and [7,12-14C]dimethylbenz[a]anthracene in mice.
The percutaneous penetration, tissue distribution, and excretion of 14C-labeled benzo[a]pyrene (BaP) and dimethylbenz[a]anthracene (DMBA) were studied in mice. Both BaP and DMBA rapidly penetrated the skin and were excreted more in the feces than in the urine. The proportion of BaP or DMBA absorbed was less with increasing applied dose due to apparent saturation of the uptake process. Uptake from the dorsal skin of the nose was similar to uptake from the dorsal nuchal skin.
D015127:9,10-Dimethyl-1,2-benzanthracene / Q000378:metabolism* / Q000652:urine; D000287:Administration, Topical; D000818:Animals; D001551:Benz(a)Anthracenes / Q000378:metabolism*; D001564:Benzo(a)pyrene; D001580:Benzopyrenes / Q000378:metabolism* / Q000652:urine; D002250:Carbon Radioisotopes; D005243:Feces / Q000032:analysis; D051379:Mice; D012869:Skin Absorption
D001551:Benz(a)Anthracenes; D001580:Benzopyrenes; D002250:Carbon Radioisotopes; D001564:Benzo(a)pyrene; D015127:9,10-Dimethyl-1,2-benzanthracene